Postpartum thyroiditis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(17 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Postpartum thyroiditis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Postpartum_thyroiditis]]
{{CMG}} {{AE}} {{MMF}}
{{CMG}} {{AE}} {{MMF}}{{SKA}}


==Overview==
==Overview==
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As Postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis.
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis.


==Differentiating Postpartum Thyroiditis from other Diseases==
==Differentiating Postpartum Thyroiditis from other Diseases==
===Differentiating postpartum thyroiditis from other causes of thyroiditis===
===Differentiating postpartum thyroiditis from other causes of thyroiditis===
*Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis.<ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid28781832">{{cite journal| author=Akuzawa N, Yokota T, Suzuki T, Kurabayashi M| title=Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report. | journal=Clin Case Rep | year= 2017 | volume= 5 | issue= 8 | pages= 1238-1242 | pmid=28781832 | doi=10.1002/ccr3.1048 | pmc=5538065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28781832  }}</ref>
*Postpartum thyroiditis must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis.<ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid28781832">{{cite journal| author=Akuzawa N, Yokota T, Suzuki T, Kurabayashi M| title=Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report. | journal=Clin Case Rep | year= 2017 | volume= 5 | issue= 8 | pages= 1238-1242 | pmid=28781832 | doi=10.1002/ccr3.1048 | pmc=5538065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28781832  }}</ref><ref name="pmid287818323">{{cite journal| author=Akuzawa N, Yokota T, Suzuki T, Kurabayashi M| title=Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report. | journal=Clin Case Rep | year= 2017 | volume= 5 | issue= 8 | pages= 1238-1242 | pmid=28781832 | doi=10.1002/ccr3.1048 | pmc=5538065 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28781832  }}</ref>
{| align="center"
{| align="center"
|-
|-
Line 15: Line 15:
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" | Conditions
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Causes
! style="background:#4479BA; color: #FFFFFF;" |Age at onset
! style="background:#4479BA; color: #FFFFFF;" |Age of onset (years)
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach     
Line 22: Line 22:
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-50
*All ages, peak at 30-50
Line 28: Line 28:
*Lymphocytic infiltration
*Lymphocytic infiltration
*Germinal centers
*Germinal centers
*Fibrosis (in some variants)
*[[Fibrosis]] (in some variants)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism)
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 41: Line 41:
*20-60
*20-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Giant cells
*[[Giant cells]]
*Granulomas
*[[Granulomas]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (Thyrotoxicosis)
* [[Thyroid function tests|Decreased TSH]] ([[thyrotoxicosis]])
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer
*[[I-123 thyroid imaging|I-123]] uptake decreased
*[[I-123 thyroid imaging|I-123]] uptake decreased
Line 51: Line 51:
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*All ages, peak at 30-40
*All ages, peak at 30-40
Line 58: Line 58:
*Lymphoid follicles
*Lymphoid follicles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 65: Line 65:
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Autoimmune
*[[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Childbearing age
*Childbearing age
Line 71: Line 71:
*Lymphocytic infiltration
*Lymphocytic infiltration
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or
*[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism)
* [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]])
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[Thyroid peroxidase|TPO antibodies]] present in high titer
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
*[[I-123 thyroid imaging|I-123]] uptake usually decreased
Line 82: Line 82:
*30-60
*30-60
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Dense fibrosis
*Dense [[fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 90: Line 90:
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Infection
*[[Infection]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Children, 20-40
*Children, 20-40
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Abscess formation
*[[Abscess]] formation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
*[[Thyroid function tests|Normal TSH]] (euthyroidism)
Line 120: Line 120:
|-
|-
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]]
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] ([[Hashimoto's thyroiditis]])
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]]  
([[Hashimoto's thyroiditis]])
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 146: Line 147:
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass.
|-
|-
| align="center" style="background:#DCDCDC;" |[[Infectious thyroiditis]]
| align="center" style="background:#DCDCDC;" |Infectious thyroiditis
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 219: Line 220:
| align="center" style="background:#DCDCDC;" |Trauma induced
| align="center" style="background:#DCDCDC;" |Trauma induced
|-
|-
| align="center" style="background:#DCDCDC;" |Radioiodine induced
| align="center" style="background:#DCDCDC;" |[[Radioiodine]] induced
|-
|-
| align="center" style="background:#DCDCDC;" |Thyroidectomy
| align="center" style="background:#DCDCDC;" |[[Thyroidectomy]]
|-
|-
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism
Line 237: Line 238:
|-
|-
|}
|}
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypo]]/[[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypothyroidism]] or [[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].''


===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis===
*Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
*Postpartum thyroiditis can initially present with [[thyrotoxicosis]] which must be differentiated from other causes of [[thyrotoxicosis]].<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin &#124; The BMJ |format= |work= |accessdate=}}</ref>
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
Line 250: Line 251:
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Free T4  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>†
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Thyroglobin  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH  
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody
Line 328: Line 329:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Patient may have opthalmopathy and dermopathy
* Opthalmopathy and [[dermopathy]] may be present
|-
|-
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]]
Line 357: Line 358:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]]  
Line 372: Line 373:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Inappropriately normal or increased TSH
*Inappropriately normal or increased [[TSH]]
|-
|-
| rowspan="2" style="background:#DCDCDC;" |Drug induced
| rowspan="2" style="background:#DCDCDC;" |Drug induced
Line 387: Line 388:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]]
Line 401: Line 402:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*High urinary iodine
*High urinary [[iodine]]
|-
|-
| rowspan="3" style="background:#DCDCDC;" |Others
| rowspan="3" style="background:#DCDCDC;" |Others
Line 416: Line 417:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*Decreased thyroglobulin
*Decreased [[thyroglobulin]]
|-
|-
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]]
Line 449: Line 450:
<small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small>
<small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small>


===Differentiating various diseases on the basis of type of thyroid dysfunction===
{| class="wikitable"
{| class="wikitable"
!
! rowspan="2" |Stages
!
! rowspan="2" |Peek
presenting
purpural
month
! rowspan="2" |Disease
! colspan="4" |Symptoms and Signs
! colspan="4" |Symptoms and Signs
! colspan="7" |Labs
! colspan="7" |Labs
!Mechanisum
! rowspan="2" |Mechanisum
|-
|-
!
!
!Fatiuge
!Fatiuge
!Neck
!Neck
Line 475: Line 479:


Picture
Picture
!aetology
|-
|-
!Persistent
!Persistent
hyperthyroidism
hyperthyroidism
![[Grave's disease]]
|4-6
!+
|[[Grave's disease]]
!Small
| +
|Small
painful
painful
mass
mass
!Present
| +
!Present
| +
early
Early
!Low
|↓
!High
|↑↑
!Absent
|Neg
!
|
!
|
!diffusely
|Diffusely
enlarged
enlarged
hypervascular
hypervascular


Line 500: Line 506:
echotexture
echotexture


!
|hyperplastic
 
hyperplastic


follicles due to  
follicles due to  
Line 511: Line 515:


scalloping
scalloping
!
|TSHR
 
activating
 
antibodies
|-
|-
! rowspan="5" |Transient
! rowspan="5" |Transient
hyperthyroidism
hyperthyroidism
![[Silent thyroiditis]]
| rowspan="5" |2-4
!+
|[[Silent thyroiditis]]
!Small
| +
painless
|Small
painless  
 
goiter
goiter
!Present
| +
late
Late
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!50%
|50%
!NL
|NL
!
|
!markedly
|Markedly
decreased
decreased


Line 542: Line 552:
texture
texture


!Lymphocytic
|Lymphocytic
 
infiltration & follicles


infiltration
|CD4


Lymphoid
T-cell


follicles
activation


!
mutation
|-
|-
![[Postpartum thyroiditis]]
|[[Postpartum thyroiditis]]
!+
| +
!Small
|Small
painless  
painless goiter
goiter
| +
!Present
Late
late
| +
!Present
Early
early
|NL
!Normal


or Low
or
!High
|↑↑
!>80% 
|>80% 
!
|
!
|
!hypoechoic
|Hypoechoic
diffusely
diffusely


Line 579: Line 590:
or decreased
or decreased


vasclarity
vascularity
!variable
|Lymphocytic
 
infiltration & follicles
|Reg
 
T-cell


heterogeneous
gain in


texture
function


hypoechogenic
mutation
!
|-
|-
![[De Quervain's thyroiditis|Subacute (de Quervain's)]]
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
!+
| +
!Small
|Small
painful  
painful  
mass
mass
!Present
| +
late
late
!Present
| +
early
early
!Normal
|nl


or Low
or
!High
|↑↑
!Absent
|neg
!
|
!
|
!diffusely
|Diffusely
enlarged &
enlarged &


Line 613: Line 629:
decreased
decreased


 vasclarity
 vascularity
!Giant cells
|Giant cells
 
granulomas
 
|Systemic


Granulomas
viral


!
infections
|-
|-
![[Factitious thyrotoxicosis|Factitious]]
|[[Factitious thyrotoxicosis|Factitious]]
[[Factitious thyrotoxicosis|thyrotoxicosis]]
[[Factitious thyrotoxicosis|thyrotoxicosis]]
!+
| +
!Normal
|Nl
!Absent
|Neg
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!Absent
|Neg
!NL
|NL
!
|
!Normal
|NL
!Normal  
|Normal


histology
histology
!
|Thyroixine
 
intake
|-
|-
!acute suppurative  
|Acute suppurative  
thyroiditis
thyroiditis
!+
| +
!Small
|Small
painful
painful
mass
mass
!Present
| +
late
Late
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!Absent
|Neg
!
|
!
|
!variable
|Variable
heterogeneous
heterogeneous


Line 668: Line 691:
space due to
space due to


abcess
abscess
!
|Polymorphonuclear
!
leukocytes
 
lymphocytes
 
exudates
|Viral, Bacterial
|-
|-
! rowspan="3" |Destructive
! rowspan="3" |Destructive
hyperthyroidism
hyperthyroidism
![[De Quervain's thyroiditis|Subacute (de Quervain's)]]  
| rowspan="3" |4-6
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]  
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
[[De Quervain's thyroiditis|granulomatous thyroiditis]]
!+
| +
!Small
|Small
painful  
painful  
mass
mass
!Present
| +
late
Late
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!Absent
|Neg
!
|
!
|
!diffusely
|Diffusely
enlarged  
enlarged  


&normal or
& normal or


decreased
decreased


 vasclarity
 vascularity
!Giant cells
|Gaint cells
 
granulomas
 
|Systemic


Granulomas
viral


!
infections
|-
|-
![[Postpartum thyroiditis|Postpartum]]
|[[Postpartum thyroiditis|Postpartum]]
[[Postpartum thyroiditis|thyroiditis]]
[[Postpartum thyroiditis|thyroiditis]]
!+
| +
!Small
|Small
painless
painless
goiter
goiter
!Present
| +
late
Late
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!>80% 
|>80% 
!
|
!
|
!hypoechoic
|Hypoechoic
diffusely
diffusely


Line 731: Line 766:
decreased
decreased


vasclarity
vascularity
!variable
|Lymphocytic
infiltration &
follicles
|Reg
 
T-cell


heterogeneous
gain in


texture
function


hypoechogenic
mutation
!
|-
|-
!acute suppurative  
|Acute suppurative  
thyroiditis
thyroiditis
!+
| +
!Small
|Small
painful  
painful  
mass
mass
!Present
| +
late
Late
!Present
| +
early
Early
!Normal
|NL


or Low
or
!High
|↑↑
!Absent
|neg
!
|
!
|
!variable
|Variable
heterogeneous
heterogeneous


Line 769: Line 809:
space due to
space due to


abcess
abscess
!
|Polymorphonuclear leukocytes
!
 
lymphocytes
 
exudates
 
|Viral,
 
Bacterial
|-
|-
| rowspan="4" |'''Transient'''
! rowspan="4" |'''Transient'''
'''hypothyroidism'''
'''hypothyroidism'''
| rowspan="4" |2-4
|[[Postpartum thyroiditis|Postpartum]]
|[[Postpartum thyroiditis|Postpartum]]
[[Postpartum thyroiditis|thyroiditis]]
[[Postpartum thyroiditis|thyroiditis]]
Line 780: Line 828:
|Small
|Small
painless
painless
goiter
goiter
|Present
| +
late
Late
|Present
| +
early
Early
|Normal
|NL


or High
or
|Low
|
|>80% 
|>80% 
|↑
|↑
|↓
|↓
| hypoechoic
| Hypoechoic
diffusely
diffusely


Line 802: Line 851:


vasclarity
vasclarity
|variable
|Lymphocytic
infiltration &
follicles
|Reg
 
T-cell


heterogeneous
gain in


texture
function


, hypoechogenic
mutation
|
|-
|-
|[[Silent thyroiditis|Silent]]
|[[Silent thyroiditis|Silent]]
Line 815: Line 868:
| +
| +
|Small
|Small
painless  
painless
 
goiter
goiter
|Present
| +
late
Late
|Present
| +
early
Early
|Normal
|NL


or High
or
|Low
|
|Present
| +
|NL
|NL
|↓
|↓
|markedly
|Markedly
decreased
decreased


Line 840: Line 894:


|Lymphocytic infiltration
|Lymphocytic infiltration
& follicles
|CD4


Lymphoid follicles
T-cell


|
activation
 
mutation
|-
|-
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]]
Line 850: Line 909:
|Small
|Small
painful
painful
mass
mass
|Present
| +
late
Late
|Present
| +
early
Early
|Normal
|NL


or High
or
|Low
|
|Absent
|Neg
|↑
|↑
|↓
|↓
|diffusely
|Diffusely
enlarged
enlarged


Line 870: Line 930:


 vasclarity
 vasclarity
|Giant cells
|Giant cells &
 
granulomas
 
|Systemic


Granulomas
viral


|
infections
|-
|-
|[[Infectious thyroiditis|acute suppurative]]
|Acute suppurative
[[Infectious thyroiditis|thyroiditis]]
thyroiditis
| +
| +
|Small
|Small
painful  
painful
 
mass
mass
|Present
| +
late
Late
|Present
| +
early
Early
|Normal
|NL


or High
or
|Low
|
|Absent
|Neg
|↑
|↑
|↓
|↓
|variable
|Variable
heterogeneous
heterogeneous


Line 905: Line 970:


abcess
abcess
|
|Polymorphonuclear leukocytes
|
 
lymphocytes
 
exudates
|Infections
 
viral,bacterial
|-
|-
| rowspan="4" |'''Persistent'''
! rowspan="4" |'''Persistent'''
'''hypothyroidism'''
'''hypothyroidism'''
| rowspan="4" |6
|[[Riedel's thyroiditis|Riedel's]]
|[[Riedel's thyroiditis|Riedel's]]
[[Riedel's thyroiditis|thyroiditis]]
[[Riedel's thyroiditis|thyroiditis]]
| +
| +
|Small
|Small
painful  
painful
 
mass
mass
|Present
| +
late
Late
|Present
| +
early
Early
|High
|
|Low
|
|75%
|75%
|↑
|↑
|↓
|↓
|homogeneously
|Homogeneously
hypoechoic
hypoechoic


Line 935: Line 1,008:


structures
structures
|
|Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue
|
|Viral
Bacterial
|-
|-
|[[Postpartum thyroiditis|Postpartum]]
|[[Postpartum thyroiditis|Postpartum]]
Line 943: Line 1,017:
|Small
|Small
painless  
painless  
goiter
goiter
|Present
| +
late
Late
|Present
| +
early
Early
|High
|
|Low
|
|>80% 
|>80% 
|↑
|↑
|↓
|↓
|hypoechoic
|Hypoechoic
diffusely
diffusely


Line 963: Line 1,038:


vasclarity
vasclarity
|variable
|Variable


heterogeneous
heterogeneous
Line 970: Line 1,045:


hypoechogenic
hypoechogenic
|
|Reg
 
T-cell
 
gain in
 
function
 
mutation
|-
|-
|[[Hashimoto's thyroiditis|Hashimoto's]]
|[[Hashimoto's thyroiditis|Hashimoto's]]
Line 977: Line 1,060:
|Painful
|Painful
mass
mass
|Present
| +
late
Late
|Present
| +
early
Early
|High
|
|Low
|
|95%
|95%
|↑
|↑
|↓
|↓
|heterogeneous
|Heterogeneous
echotexture
echotexture


Line 996: Line 1,079:


micronodules
micronodules
|lymphoid
|Lymphoid


follicles
follicles


Germinal centers
germinal centers
 
Hurthle cells
 
|Reg T-cell


|
dysfunction
|-
|-
|Acute suppurative
|Acute suppurative
Line 1,008: Line 1,095:
| +
| +
|Small
|Small
painful
painful  
 
mass
mass
|Present
| +
late
Late
|Present
| +
early
Early
|High
|
|Low
|
|Absent
|Neg
|↑
|↑
|↓
|↓
|variable
|Variable
heterogeneous
heterogeneous


Line 1,032: Line 1,120:
abcess
abcess


|
|Polymorphonuclear leukocytes
|
 
lymphocytes
 
exudates
|Systemic
 
viral
 
infections
|}
|}



Latest revision as of 19:21, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]Sunny Kumar MD [3]

Overview

Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.

Differentiating Postpartum Thyroiditis from other Diseases

Differentiating postpartum thyroiditis from other causes of thyroiditis

Conditions Causes Age of onset (years) Pathological findings Diagnostic approach
Hashimoto's thyroiditis
  • All ages, peak at 30-50
  • Lymphocytic infiltration
  • Germinal centers
  • Fibrosis (in some variants)
Painful subacute (De Quervain's) thyroiditis
  • Unknown
  • 20-60
Silent thyroiditis
  • All ages, peak at 30-40
  • Lymphocytic infiltration
  • Lymphoid follicles
Postpartum thyroiditis
  • Childbearing age
  • Lymphocytic infiltration
Riedel's thyroiditis
  • Unknown
  • 30-60
Suppurative thyroiditis
  • Children, 20-40

Differentiating postpartum thyroiditis from other causes of hypothyroidism

  • Postpartum thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[4][5][1][6][7][8]
Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TPOAb^
Primary hypothyroidism Autoimmune

(Hashimoto's thyroiditis)

- - * Normal/ Normal/↓ Normal/ Normal Present (high titer)
Riedel's thyroiditis - - Normal/↑ Normal/↓ Normal/↓ Normal/↓ Normal Normal Usually present
Infectious thyroiditis + + Normal Normal Normal Normal Normal Normal Absent
Transient hypothyroidism Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Low/absent
Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Present (high titer)
Silent thyroiditis - - ↑/ ↓/ Normal Normal Present (high titer)
Others Drug-induced - - /↓ /↑ Normal Normal/ Normal Absent**
  • History of hyperthyroidism
  • History of trauma
  • History of drug use, surgery, or radiation
Radiation-induced
Trauma induced
Radioiodine induced
Thyroidectomy
Subclinical hypothyroidism - - Normal Normal Normal Normal Normal Normal/
  • Asymptomatic


(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypothyroidism or hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.

Differentiating postpartum thyroiditis from other causes of thyrotoxicosis

Disease History and symptoms Laboratory findings Additional findings
Fever Pain TSH Free T4 T3 T3RU Thyroglobin TRH TSH Receptor Antibody TPOAb^
Thyroiditis Postpartum thyroiditis +/- +/- ↑/ ↓/ Normal Normal/↑ Absent Present (high titer)
Hashimoto's thyroiditis (Hashitoxicosis) - - * Normal/ Normal/↓ Normal/ Normal Absent Present (high titer)
Subacute (de Quervain's) thyroiditis +/- +/- ↑/ ↓/ Normal Normal Absent Low/absent
Silent thyroiditis - - ↑/ ↓/ Normal Normal Absent Present (high titer)
Primary hyperthyroidism Grave's disease - - Normal/ Normal Present Absent
Toxic thyroid nodule - - Normal/↑ ↑(hot nodule) Normal/ Normal Absent Absent

-

Secondary hyperthyroidism Pituitary adenoma - - Normal/↑ Normal/ Normal Absent Absent
  • Inappropriately normal or increased TSH
Tertiary hyperthyroidism Tertiary hyperthyroidism - - Normal/ Absent Absent
  • Inappropriately normal or increased TSH
Drug induced Amiodarone type 1 - - Normal/↑ Normal/ Normal Absent Absent
Amiodarone type 2 - - Normal/↑ Absent/↓ Normal/ Normal Absent Absent
Others Factitious thyrotoxicosis - - Normal/↑ Normal Absent Absent
Trophoblastic disease - - Normal/↑ - Normal Absent Absent

-

Struma ovarii - - Normal/↑ - Normal Absent Absent

-

(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.

Differentiating various diseases on the basis of type of thyroid dysfunction

Stages Peek

presenting purpural month

Disease Symptoms and Signs Labs Mechanisum
Fatiuge Neck

swelling

Low

mood

Irritability TSH FT4 TPO ab ESR RAI

U

Thyroid U/S Microscopic

Picture

Persistent

hyperthyroidism

4-6 Grave's disease + Small

painful

mass

+ +

Early

↑↑ Neg Diffusely

enlarged

hypervascular

heterogeneous

echotexture

hyperplastic

follicles due to

eosinophilic

cytoplasm

scalloping

TSHR

activating

antibodies

Transient

hyperthyroidism

2-4 Silent thyroiditis + Small

painless

goiter

+

Late

+

Early

NL

or ↓

↑↑ 50% NL Markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic

infiltration & follicles

CD4

T-cell

activation

mutation

Postpartum thyroiditis + Small

painless goiter

+

Late

+

Early

NL

or ↓

↑↑ >80%  Hypoechoic

diffusely

enlarged

with

normal

or decreased

vascularity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

late

+

early

nl

or ↓

↑↑ neg Diffusely

enlarged &

normal or

decreased

 vascularity

Giant cells

granulomas

Systemic

viral

infections

Factitious

thyrotoxicosis

+ Nl Neg +

Early

NL

or ↓

↑↑ Neg NL NL Normal

histology

Thyroixine

intake

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abscess

Polymorphonuclear

leukocytes

lymphocytes

exudates

Viral, Bacterial
Destructive

hyperthyroidism

4-6 Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ Neg Diffusely

enlarged

& normal or

decreased

 vascularity

Gaint cells

granulomas

Systemic

viral

infections

Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↓

↑↑ >80%  Hypoechoic

diffusely

enlarged&

normal or

decreased

vascularity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↓

↑↑ neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abscess

Polymorphonuclear leukocytes

lymphocytes

exudates

Viral,

Bacterial

Transient

hypothyroidism

2-4 Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↑

>80%   Hypoechoic

diffusely

enlarged

& normal or

decreased

vasclarity

Lymphocytic

infiltration & follicles

Reg

T-cell

gain in

function

mutation

Silent

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

NL

or ↑

+ NL Markedly

decreased

vascularity

variable

heterogeneous

texture

Lymphocytic infiltration

& follicles

CD4

T-cell

activation

mutation

Subacute (de Quervain's)

granulomatous thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↑

Neg Diffusely

enlarged

normal or

decreased

 vasclarity

Giant cells &

granulomas

Systemic

viral

infections

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

NL

or ↑

Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

Polymorphonuclear leukocytes

lymphocytes

exudates

Infections

viral,bacterial

Persistent

hypothyroidism

6 Riedel's

thyroiditis

+ Small

painful

mass

+

Late

+

Early

75% Homogeneously

hypoechoic

fibrotic

invasion of the

adjacent

structures

Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue Viral

Bacterial

Postpartum

thyroiditis

+ Small

painless

goiter

+

Late

+

Early

>80%  Hypoechoic

diffusely

enlarged&

normal

or decreased

vasclarity

Variable

heterogeneous

texture,

hypoechogenic

Reg

T-cell

gain in

function

mutation

Hashimoto's

thyroiditis

+ Painful

mass

+

Late

+

Early

95% Heterogeneous

echotexture

decreased

vasclarity

hypoechoic

micronodules

Lymphoid

follicles

germinal centers

Hurthle cells

Reg T-cell

dysfunction

Acute suppurative

thyroiditis

+ Small

painful

mass

+

Late

+

Early

Neg Variable

heterogeneous

texture

perithyroidal

hypoechoic

space due to

abcess

Polymorphonuclear leukocytes

lymphocytes

exudates

Systemic

viral

infections

References

  1. 1.0 1.1 1.2 "Thyroiditis — NEJM".
  2. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  3. Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
  4. 4.0 4.1 Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
  5. 5.0 5.1 McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
  6. 6.0 6.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
  7. 7.0 7.1 Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
  8. 8.0 8.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.
  9. "Clinical Finding and Thyroid Function in Women with Struma Ovarii".
  10. Vaidya B, Pearce SH (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. PMID 25146390.
  11. "Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ".

Template:WH Template:WS